1. Home
  2. WS vs IBRX Comparison

WS vs IBRX Comparison

Compare WS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WS
  • IBRX
  • Stock Information
  • Founded
  • WS 1955
  • IBRX 2014
  • Country
  • WS United States
  • IBRX United States
  • Employees
  • WS N/A
  • IBRX N/A
  • Industry
  • WS
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WS
  • IBRX Health Care
  • Exchange
  • WS Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • WS 2.2B
  • IBRX 1.9B
  • IPO Year
  • WS N/A
  • IBRX N/A
  • Fundamental
  • Price
  • WS $31.06
  • IBRX $3.22
  • Analyst Decision
  • WS Buy
  • IBRX Strong Buy
  • Analyst Count
  • WS 2
  • IBRX 3
  • Target Price
  • WS $40.00
  • IBRX $13.58
  • AVG Volume (30 Days)
  • WS 442.2K
  • IBRX 6.3M
  • Earning Date
  • WS 12-18-2024
  • IBRX 11-12-2024
  • Dividend Yield
  • WS 2.08%
  • IBRX N/A
  • EPS Growth
  • WS 12.14
  • IBRX N/A
  • EPS
  • WS 2.85
  • IBRX N/A
  • Revenue
  • WS $3,289,800,000.00
  • IBRX $7,332,000.00
  • Revenue This Year
  • WS N/A
  • IBRX $2,515.60
  • Revenue Next Year
  • WS $0.86
  • IBRX $766.19
  • P/E Ratio
  • WS $10.81
  • IBRX N/A
  • Revenue Growth
  • WS N/A
  • IBRX 1218.71
  • 52 Week Low
  • WS $28.20
  • IBRX $2.28
  • 52 Week High
  • WS $47.19
  • IBRX $10.53
  • Technical
  • Relative Strength Index (RSI)
  • WS 38.39
  • IBRX 54.04
  • Support Level
  • WS $29.94
  • IBRX $2.28
  • Resistance Level
  • WS $31.06
  • IBRX $3.30
  • Average True Range (ATR)
  • WS 1.08
  • IBRX 0.26
  • MACD
  • WS 0.35
  • IBRX 0.13
  • Stochastic Oscillator
  • WS 58.33
  • IBRX 92.16

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.

Share on Social Networks: